DR. MICHAEL MAGUIRE, CEO
Dr. Maguire, CEO, is a biomedical engineer with 20 years experience in the commercial sector. The initial years of his career were as a biomedical design engineer with a medical device manufacturer with US and European operations. There, he managed teams that developed medical devices and brought them through the FDA regulatory approval process for sale in the US market. Dr. Maguire has an entrepreneurial track record. He has operated as a business owner, director, founder and partner. He has a deep understanding of the technology underpinning the Spraybase® family of instruments and has a vision for the evolving role of electrospinning and electrospraying technologies in life sciences.
DR.Shirley O'Dea, CSO
Dr. O’Dea is CSO at Avectas, the makers of Spraybase® and an inventor of the Spraybase® technology. She has guided the development of electrospray mediated transfection over eight years and has secured funding from Irish and EU supports to develop the technology. Dr. O’Dea has a network of current and future customers; academic peers, collaborators and KOLs. She is charged with overseeing all scientific activities and formulating long-term visions and strategies. Dr. O’Dea also leads a research team which is investigating lung regeneration mechanisms in health and disease in order to identify potential target cells for regeneration therapies, gene therapy and cancer treatments. This basic research will provide strong pipeline of applications for the Avectas technology, specifically, in the area of translation where our technology can be used as a diagnostic and therapeutic device.
DR. Gillian Hendy
Dr. Gillian Hendy is Director, Spraybase® Instruments at Avectas. Dr. Hendy received her BSc in chemistry and her doctorate in electrochemistry and drug delivery from National University of Ireland, Maynooth in 2005 and 2009, respectively. Following this she was awarded a prestigious Marie Curie International outgoing fellowship and subsequently carried out a postdoctoral fellowship at MIT, Cambridge, under the supervision of Dr. Robert Langer. She also carried out a research fellowship at the University of Wollongong, Australia with Dr. Gordon Wallace and gained her electrospinning experience from Dr. Dan Li. Dr. Hendy has published in two peer reviewed journal articles as well as 7 international conference proceedings.
DR. Shane Finnegan
Dr. Shane Finnegan is Chief Product Designer at Spraybase® . Dr. Finnegan achieved his PhD in Mechanical Engineering from Trinity College Dublin in 2011 where his field of research was the aeroacoustic behavior of ducted bluff body flows subject to acoustic resonance. Dr. Finnegan was particularly interested in experimentally measuring the fluid structure and acoustic response of tube arrays. He has considerable experience in fluid flow measurement, fluid flow visualisation, acoustic measurement, data analysis and signal processing. Dr. Finnegan’s research has been published in two peer reviewed journal articles that have strong academic and industrial interest as well as five peer reviewed international conference proceedings. Dr. Finnegan also holds an honours degree in Engineering from Trinity College Dublin (BA, BAI) where he was conferred with a Gold Medal. Since starting with Avectas, Dr. Finnegan has concentrated on visualising and optimising the electrospray and electrospinning process and product development. Dr. Finnegan was born in Calgary, Canada but has lived in Dublin with his family since 1998.
|Prof. Daniel Anderson||MIT, Koch Institute, Langer Laboratory|
|Dr. Paul Burke||Principal, Burke Bioventures LLC. Pfizer, Merck, Amgen|
|Prof. Roy Curry||UC Davis, Department of Physiology and Membrane Biology|
|Dr. Ben Kleinstiver||Harvard Medical School, Mass General Hospital|
|Prof. Mark Lowdell||UCL, Royal Free Hospital, London|
Board of Directors
|Board of Directors||Background|
|Mr. Eunan Maguire||Azur, Adapt, Jazz, King, Elan|
|Dr. Ann Brady||Theravance Biopharma, Shire, Elan|
|Dr. Mary Martin||Horizon, Vidara, AGI, Elan|
|Mr. Barry Leonard||DCC Healthcare, Virtus|
|Mr. Barry Wohl||Medtronic, IMS Health, Symbal, Macrolide|